News
Synchrony Medical announced that it received FDA 510 (k) clearance for its LibAirty airway clearance system.
Capricor Therapeutics (CAPR) shares fell Friday after the company announced it received a complete response letter from the FDA for its Biologics License Application for Deramiocel.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback